Rare diseases
Investigational molecules
Locations
Retzius Vag 8, 171 65 Solna, Sweden
Cellcolabs AB is engaged in clinical research centered on mesenchymal stromal cells and cell-based therapy, with attention to their long-term use in human treatment settings.
The sponsor’s current research activity is directed toward evaluating the enduring safety profile of MSC administration in a clinical context.
Cellcolabs AB runs clinical trials in conditions such as Stem cell therapy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
